Prescription drug benefits

FILE- In this Oct. 26, 2018, file photo Health and Human Services Secretary Alex Azar speaks about proposed reforms to Medicare Part B drug pricing policies at the Brookings Institute in Washington. The Trump administration says it is moving ahead with a plan to let patients directly receive prescription drug discounts negotiated behind-the-scenes between drugmakers, middlemen, and insurers. Azar said Thursday, Jan. 31, 2019, the proposed regulation would encourage the major industry players to channel any such discounts to consumers when they purchase their prescriptions. (AP Photo/Alex Brandon, File)
January 31, 2019 - 7:12 pm
WASHINGTON (AP) — The Trump administration Thursday unveiled a plan to channel now-hidden prescription drug rebates directly to patients, saying it would bypass middlemen and lower prices for consumers. The proposed regulation from Health and Human Services Secretary Alex Azar would eliminate...
Read More
FILE- In this Oct. 26, 2018, file photo Health and Human Services Secretary Alex Azar speaks about proposed reforms to Medicare Part B drug pricing policies at the Brookings Institute in Washington. The Trump administration says it is moving ahead with a plan to let patients directly receive prescription drug discounts negotiated behind-the-scenes between drugmakers, middlemen, and insurers. Azar said Thursday, Jan. 31, 2019, the proposed regulation would encourage the major industry players to channel any such discounts to consumers when they purchase their prescriptions. (AP Photo/Alex Brandon, File)
January 31, 2019 - 6:24 pm
WASHINGTON (AP) — The Trump administration Thursday unveiled a plan to channel now-hidden prescription drug discounts directly to patients, saying that would eventually lower prices for consumers. The proposed regulation from Health and Human Services Secretary Alex Azar aims to eliminate behind-...
Read More
FILE- In this Oct. 26, 2018, file photo Health and Human Services Secretary Alex Azar speaks about proposed reforms to Medicare Part B drug pricing policies at the Brookings Institute in Washington. The Trump administration says it is moving ahead with a plan to let patients directly receive prescription drug discounts negotiated behind-the-scenes between drugmakers, middlemen, and insurers. Azar said Thursday, Jan. 31, 2019, the proposed regulation would encourage the major industry players to channel any such discounts to consumers when they purchase their prescriptions. (AP Photo/Alex Brandon, File)
January 31, 2019 - 5:02 pm
WASHINGTON (AP) — The Trump administration says it is moving ahead with a plan to channel behind-the-scenes prescription drug discounts directly to consumers. Health and Human Services Secretary Alex Azar said Thursday his proposed regulation would encourage drugmakers, middlemen and insurers to...
Read More
January 31, 2019 - 4:55 pm
WASHINGTON (AP) — The Trump administration says it is moving ahead with a plan to channel behind-the-scenes prescription drug discounts directly to consumers. Health and Human Services Secretary Alex Azar said Thursday his proposed regulation would encourage drugmakers, middlemen and insurers to...
Read More
FILE - In this June 14, 2011, file photo, various prescription drugs on the automated pharmacy assembly line at Medco Health Solutions in Willingboro, N.J. The Trump administration is unveiling complex policy changes to Medicare’s prescription drug benefit that would affect beneficiaries’ costs over the next few years. (AP Photo/Matt Rourke, File)
November 26, 2018 - 5:29 pm
WASHINGTON (AP) — The Trump administration on Monday proposed changes to Medicare's prescription drug benefit that would affect people's costs over the next few years, and create winners and losers. Medicare's administrator, Seema Verma, said the goal is to lower costs for beneficiaries and...
Read More
President Donald Trump talks about drug prices during a visit to the Department of Health and Human Services in Washington, Thursday, Oct. 25, 2018. (AP Photo/Susan Walsh)
October 26, 2018 - 1:13 am
WASHINGTON (AP) — Less than two weeks before the midterm elections, President Donald Trump has announced a plan to lower prices for some prescription drugs, saying it would stop unfair practices that force Americans to pay much more than people in other countries for the same medications. "We are...
Read More
FILE- In this July 10, 2018, file photo bottles of medicine ride on a belt at the Express Scripts mail-in pharmacy warehouse in Florence, N.J. On Monday, Oct. 15, the industry's largest trade group announced that dozens of drugmakers will start disclosing the prices for U.S. prescription drugs advertised on TV. The prices won't actually be shown in the TV commercials but the advertisement will include a website where the list price will be posted. (AP Photo/Julio Cortez, File)
October 15, 2018 - 9:41 pm
TRENTON, N.J. (AP) — The federal government said Monday that it wants to force drugmakers to disclose prices for prescription medicines in their TV commercials. The drug industry's main trade group said drug companies are only willing to disclose the prices on their websites, not in commercials,...
Read More
FILE - In this June 14, 2011, file photo, various prescription drugs on the automated pharmacy assembly line at Medco Health Solutions in Willingboro, N.J. Medicare recipients cut back on pricey brand-name drugs but they still had to spend more on such medications anyway, according to a government report that blames rising manufacturer prices for squeezing older people and taxpayers. (AP Photo/Matt Rourke, File)
June 04, 2018 - 9:49 am
WASHINGTON (AP) — Medicare recipients filled fewer prescriptions for pricey brand-name drugs — but spent more on such meds anyway, says a government report released Monday. It blames rising manufacturer prices for squeezing older people and taxpayers. The Health and Human Services inspector general...
Read More
FILE - In this June 14, 2011, file photo, various prescription drugs on the automated pharmacy assembly line at Medco Health Solutions in Willingboro, N.J. Medicare recipients cut back on pricey brand-name drugs but they still had to spend more on such medications anyway, according to a government report that blames rising manufacturer prices for squeezing older people and taxpayers. (AP Photo/Matt Rourke, File)
June 04, 2018 - 6:10 am
WASHINGTON (AP) — Medicare recipients filled fewer prescriptions for pricey brand-name drugs — but spent more on such meds anyway, says a government report due out Monday. It blames rising manufacturer prices for squeezing older people and taxpayers. The Health and Human Services inspector general'...
Read More
FILE - In this June 14, 2011, file photo, various prescription drugs on the automated pharmacy assembly line at Medco Health Solutions in Willingboro, N.J. Medicare recipients cut back on pricey brand-name drugs but they still had to spend more on such medications anyway, according to a government report that blames rising manufacturer prices for squeezing older people and taxpayers. (AP Photo/Matt Rourke, File)
June 04, 2018 - 12:59 am
WASHINGTON (AP) — Medicare recipients filled fewer prescriptions for pricey brand-name drugs — but spent more on such meds anyway, says a government report due out Monday. It blames rising manufacturer prices for squeezing older people and taxpayers. The Health and Human Services inspector general'...
Read More

Pages